论文部分内容阅读
目的分析曲美他嗪治疗冠心病合并左心功能不全的临床效果。方法在2015年3月至2016年9月期间到我院心血管科中接受治疗的冠心病合并左心功能不全患者中随机性的选择104例,根据治疗方案的差异,将参与试验的患者分别定义为对照组以及试验组两个不同的小组,对照组为52例,采取常规的药物进行治疗,试验组为52例,采取曲美他嗪进行治疗,对比两组患者的临床疗效。结果疗程结束后,对照组患者的总有效率为84.62%(44/52),试验组患者的总有率为94.23%(49/52),不同小组患者的临床疗效进行比较,试验组患者的临床疗效存在显著的优势,组间数据差异明显,(P<0.05),具有统计学意义。结论曲美他嗪治疗冠心病合并左心功能不全的临床效果比较显著,具有在临床上广泛推广的价值。
Objective To analyze the clinical effect of trimetazidine on patients with coronary heart disease complicated with left ventricular dysfunction. Methods From March 2015 to September 2016 in our hospital cardiovascular department to be treated in patients with coronary heart disease complicated with left ventricular dysfunction in 104 patients randomly selected, according to the difference in treatment options, will participate in the trial patients Defined as the control group and the experimental group two different groups, the control group was 52 cases, taking conventional drugs for treatment, the experimental group was 52 cases, taking trimetazidine treatment, compared the clinical efficacy of the two groups of patients. Results After the treatment, the total effective rate of the control group was 84.62% (44/52), the total rate of the experimental group was 94.23% (49/52), the clinical efficacy of different groups of patients were compared, the patients in the experimental group There was a significant clinical advantage, with significant differences between groups (P <0.05), with statistical significance. Conclusion Trimetazidine treatment of coronary heart disease with left ventricular dysfunction more significant clinical effect, with the clinical widely value.